REVELATION BIOSCIENCES INC (REVB) Stock Analyst Ratings
NASDAQ:REVB • US76135L8046
1.48 USD
+0.02 (+1.37%)
Last: Feb 13, 2026, 10:24 AM
ChartMill assigns a Buy % Consensus number of 83% to REVB. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 86.7. This target is 5758.11% above the current price.
- REVB was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about REVB.
- In the previous month the buy percentage consensus was at a similar level.
- REVB was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-14 | Roth MKM | Maintains | Buy |
| 2022-02-17 | Roth Capital | Initiate | Buy |
REVELATION BIOSCIENCES INC / REVB FAQ
Can you provide the average price target for REVELATION BIOSCIENCES INC stock?
7 analysts have analysed REVB and the average price target is 86.7 USD. This implies a price increase of 5758.11% is expected in the next year compared to the current price of 1.48.
Can you provide the consensus rating for REVELATION BIOSCIENCES INC stock?
The consensus rating for REVELATION BIOSCIENCES INC (REVB) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for REVELATION BIOSCIENCES INC stock?
The number of analysts covering REVELATION BIOSCIENCES INC (REVB) is 7.